State Board of Administration of Florida Retirement System’s Ovid Therapeutics OVID Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,230	Closed	-$55.5K	–	2371
2023 Q4	$55.5K	Hold	17,230	–	–	﹤0.01%	2325
2023 Q3	$66.2K	Buy	17,230 +300	+2%	+$1.08K	﹤0.01%	2303
2023 Q2	$55.5K	Buy	+16,930	New	+$57.5K	﹤0.01%	2379
2021 Q2	–	Sell	-21,739	Closed	-$87K	–	2415
2021 Q1	$87K	Hold	21,739	–	–	﹤0.01%	2319
2020 Q4	$50K	Hold	21,739	–	–	﹤0.01%	2332
2020 Q3	$125K	Hold	21,739	–	–	﹤0.01%	2182
2020 Q2	$160K	Buy	+21,739	New	+$102K	﹤0.01%	2132

Other funds holding OVID

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Board of Administration of Florida Retirement System's OVID Position: Q1 2024 in Review

State Board of Administration of Florida Retirement System sold out of Ovid Therapeutics (OVID) in Q1 2024, closing a stake of 17,230 shares — an estimated $55.5K sold.

State Board of Administration of Florida Retirement System first reported a position in OVID in Q2 2020 and held it in 7 quarters. The position peaked at $160K in Q2 2020. 81 funds tracked by Wall St. Rank hold OVID as of Q1 2024.

State Board of Administration of Florida Retirement System reported no remaining Ovid Therapeutics position as of Q1 2024 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 17,230 Ovid Therapeutics shares in Q1 2024, an estimated $55.5K.
State Board of Administration of Florida Retirement System first reported a position in Ovid Therapeutics in Q2 2020 and held it in 7 quarters.
State Board of Administration of Florida Retirement System's Ovid Therapeutics position peaked at $160K in Q2 2020.
81 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2024, filed 8 May 2024.